Cite
HARVARD Citation
Battisti, N. et al. (n.d.). The Oncotype DX® Breast test to guide management of nodepositive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience. Breast. pp. S17-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Battisti, N. et al. (n.d.). The Oncotype DX® Breast test to guide management of nodepositive oestrogen receptor-positive HER2-negative breast cancer patients: the United Kingdom experience. Breast. pp. S17-. [Online].